Expression of retinoic acid receptor gamma correlates with retinoic acid sensitivity and metabolism in head and neck squamous cell carcinoma cell lines

International Journal of Cancer

Volumn 92, Issue 5, 2001, Pages 661-665

  Klaassen, Ingeborg ^a   Brakenhoff, Ruud H ^a   Smeets, Serge J ^a   Snow, Gordon B ^a   Braakhuis, Boudewijn J M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cultured tumor cells; Head and neck neoplasms; Messenger RNA; Retinoic acid receptors; RNase protection; Squamous cell carcinoma; Tretinoin

Indexed keywords

MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR ALPHA; RETINOIC ACID RECEPTOR BETA; RETINOIC ACID RECEPTOR GAMMA; RETINOID; RETINOL; RIBONUCLEASE; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL GROWTH; CELL METABOLISM; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVITY; GENE EXPRESSION; GROWTH INHIBITION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TURNOVER TIME;

CARCINOMA, SQUAMOUS CELL; HEAD AND NECK NEOPLASMS; HUMANS; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TRETINOIN; TUMOR CELLS, CULTURED;

EID: 0035371906     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20010601)92:5<661::AID-IJC1251>3.0.CO;2-O     Document Type: Article

References (46)

1. Cellular biology and biochemistry of the retinoids
2. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells
3. Retinoids in cancer prevention and therapy
4. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck
5. Treatment of advanced squamous cell carcinoma of the head and neck with isotretinoin: A phase II randomized trial
6. Retinoids and human cancer
7. Lipid hydroperoxides greatly increase the rate of oxidative catabolism of all-trans-retinoic acid by human cell culture microsomes genetically enriched in specified cytochrome P-450 isoforms
8. Retinoid resistance in leukemic cells
9. Retinoid metabolism and all-trans retinoic acid-induced growth inhibition in head and neck squamous cell carcinoma cell lines
10. Enhanced turnover of all-trans-retinoic acid and increased formation of polar metabolites in head and neck squamous cell carcinoma cells compared with normal oral keratinocytes
11. Retinoids and their receptors in differentiation, embryogenesis, and neoplasia
12. Vitamin A receptors
13. 9-Cis retinoic acid is a high affinity ligand for the retinoid X receptor
14. Differential expression of nuclear retinoid receptors in normal, premalignant, and malignant head and neck tissues
15. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin
16. Abnormal expression of retinoic acid receptors and keratin 19 by human oral and epidermal squamous cell carcinoma cell lines
17. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines
18. Differential responses of normal, premalignant, and malignant human bronchial epithelial cells to receptor-selective retinoids
19. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids
20. Implication of retinoic acid receptor gamma in squamous differentiation and response to retinoic acid in head and neck SqCC/Y1 squamous carcinoma cells
21. Modulation of retinoic acid receptor function alters the growth inhibitory response of oral SCC cells to retinoids
22. Considerations for in vitro retinoid experiments: Importance of protein interaction
23. A simple and reliable technique for culturing of human oral keratinocytes and fibroblasts
24. Cell surface antigen expression and prognosis
25. Relationship between the parameters cellular differentiation, doubling time and platinum accumulation and cisplatin sensitivity in a panel of head and neck cancer cell lines
26. Importance of pharmacodynamics in the in vitro antiproliferative activity of the antifolates methotrexate and 10-ethyl-10-deazaaminopterin against human head and neck squamous cell carcinoma
27. Simultaneous analysis of retinol, all-trans- and 13-cis- retinoic acid and 13-cis-4-oxoretinoic acid in plasma by liquid chromatography using on-column concentration after single-phase fluid extraction
28. Identification and quantitation of all-trans- and 13-cis- retinoic acid and 13-cis-4-oxoretinoic acid in human plasma
29. Analytical methods
30. A reliable external control for ribonuclease protection assays
31. Retinoic acid metabolites exhibit biological activity in human keratinocytes, mouse melanoma cells and hairless mouse skin in vivo
32. The antiproliferarive activity of all-trans-retinoic acid catabolites and isomers is differentially modulated by liarozole-fumarate in MCF-7 human breast cancer cells
33. The DNA binding domain of retinoic acid receptor beta is required for ligand-dependent suppression of proliferation. Application of general purpose mammalian coexpression vectors
34. Retinoic acid receptor beta mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells
35. Retinoic acid nuclear receptor beta inhibits breast carcinoma anchorage independent growth
36. Expression of retinoic acid receptor beta mediates retinoic acid-induced growth arrest and apoptosis in breast cancer cells
37. Expression of retinoic acid receptor beta is associated with inhibition of keratinization in human head and neck squamous carcinoma cells
38. Mouse skin tumor progression results in differential expression of retinoic acid and retinoid X receptors
39. Retinoic acid metabolism and inhibition of cell proliferation: An unexpected liaison
40. Expression of a dominant-negative retinoic acid receptor construct reduces retinoic acid metabolism and retinoic acid-induced inhibition of NIH-3T3 cell growth
41. Mouse P450RAI (CYP26) expression and retinoic acid-inducible retinoic acid metabolism in F9 cells are regulated by retinoic acid receptor gamma and retinoid X receptor alpha
42. CYP26, a novel mammalian cytochrome P450, is induced by retinoic acid and defines a new family
43. cDNA cloning of human retinoic acid-metabolizing enzyme (hP450RAI) identifies a novel family of cytochromes P450
44. Retinoic acid receptors regulate expression of retinoic acid 4-hydroxylase that specifically inactivates all-trans retinoic acid in human keratinocyte HaCaT cells
45. Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells
46. Cytochrome P450RAI(CYP26) promoter: A distinct composite retinoic acid response element underlies the complex regulation of retinoic acid metabolism